doi: 10.1007/s10654-018-0366-z
GLP-1RA Cardiovascular Disease Outcomes Starting in 2008, the FDA began requiring all medications indicated for treatment of type 2 diabetes to evaluate cardiovascular risk reduction [45]
Incorporating ground flaxseeds into your meals, such as adding them to yogurt or smoothies, can be a simple way to boost your omega-3 intake and potentially support GLP-1 function
it is uncommon in African-American men and rare in Asian men
Research of novel drug treatments for diabetes has thus moved away from insulin analogs to new peptide hormones that have similar effects, in particular the incretin hormones, such as Glucagon-like peptide-1 (GLP-1), glucose-dependent insulinotropic polypeptide (GIP) and Dipeptidyl peptidase-4 (DPP-4), a key enzyme responsible for cleaving and inactivating both of GLP-1 and GIP peptides at the penultimate alanine residue ( GLP-1 is part of the peptide growth-factor family and activates a glucagon-type seven membrane-spanning G-protein coupled receptor
These GLP-1 drugs are unique in that the growth is coming so early in their patent lifecycles